• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 19, 2020 at 11:12: AM
via Combination therapies involving Roche and AbbVie’s cancer drug Venclexta have been formally approved by the FDA in acute myeloid leukaemia, following supportive data from late-stage studies.

article source
 

<



Similar threads

cafead
FDA grants full approval for Pfizer&#039;s cervical cancer drug
Replies
0
Views
77
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants full approval to AbbVie&#039;s ovarian cancer therapy
Replies
0
Views
128
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
Replies
0
Views
140
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants full approval to Keytruda in tumor-agnostic setting
Replies
0
Views
135
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants full approval to Covid-19 vaccine developed by Pfizer, BioNTech
Replies
0
Views
199
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote